Serum and synovial fluid chemokine ligand 2/monocyte chemoattractant protein 1 concentrations correlates with symptomatic severity in patients with knee osteoarthritis

Annals of Clinical Biochemistry

Volumn 52, Issue 2, 2015, Pages 276-282

  Li, Liang ^a   Jiang, Bao En ^a  

^a Dongying People s Hospital   (China)

Author keywords

chemokine ligand 2; monocyte chemoattractant protein 1; Osteoarthritis; symptomatic severity

Indexed keywords

CORTICOSTEROID; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL DISABILITY; PRIORITY JOURNAL; SELF REPORT; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; AGED; BLOOD; CHINA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; METABOLISM; PAIN MEASUREMENT; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; UPREGULATION;

AGED; BIOMARKERS; CHEMOKINE CCL2; CHINA; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; SELF REPORT; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; UP-REGULATION;

EID: 84924815659     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563214545117     Document Type: Article

References (28)

1. Goldring MB.The role of the chondrocyte in osteoarthritis.Arthritis Rheum. 2000;43:1916-1926
2. Felson DT,Naimark A,Anderson J, et al.The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study.Arthritis Rheum. 1987;30:914-922
3. Peat G,McCarney R,Croft P.Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care.Ann Rheum Dis. 2001;60:91-97
4. Woolf AD,Pfleger B.Burden of major musculoskeletal conditions.Bull World Health Organ. 2003;81:646-656
5. Gerard C,Rollins BJ.Chemokines and disease.Nat Immunol. 2001;2:108-115
6. Borzi RM,Mazzetti I,Marcu KB, et al.Chemokines in cartilage degradation.Clin Orthop Relat Res. 2004;427 (Suppl):53-61
7. Kapoor M,Martel-Pelletier J,Lajeunesse D, et al.Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.Nat Rev Rheumatol. 2011;7:33-42
8. Maghazachi AA,Al-Aoukaty A,Schall TJ.C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.J Immunol. 1994;153:4969-4977
9. Szekanecz Z,Kim J,Koch AE.Chemokines and chemokine receptors in rheumatoid arthritis.Semin Immunology. 2003;15:15-21
10. Levinger I,Levinger P,Trenerry MK, et al.Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis.Arthritis Rheum. 2011;63:1343-1348
11. Akahoshi T,Wada C,Endo H, et al.Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor.Arthritis Rheum. 1993;36:762-771
12. Gong JH,Ratkay LG,Waterfield JD, et al.An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model.J Exp Med. 1997;186:131-137
13. Miller RE,Tran PB,Das R, et al.CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis.Proc Natl Acad Sci USA. 2012;109:20602-20607
14. Qin X,Wan Y,Wang X.CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons.J Neurosci Res. 2005;82:51-62
15. Dawes JM,Kiesewetter H,Perkins JR, et al.Chemokine expression in peripheral tissues from the Monosodium Iodoacetate model of chronic joint pain.Mol Pain. 2013;8:57-57
16. Lin Y-M,Hsu C-J,Liao Y-Y, et al.The CCL2/CCR2 axis enhances vascular cell adhesion molecule-1 expression in human synovial fibroblasts.Plos One. 2012;2:1-10
17. Altman R,Asch E,Bloch D, et al.Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.Arthritis Rheum. 1986;29:1039-1049
18. Bellamy N,Buchanan WW,Goldsmith CH, et al.Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.J Rheumatol. 1988;15:1833-1840
19. Gandhi R,Razak F,Davey JR, et al.Metabolic syndrome and the functional outcomes of hip and knee arthroplasty.J Rheumatol. 2010;37:1917-1922
20. Kellgren JH,Lawrence JS.Radiological assessment of osteo-arthrosis.Ann Rheum Dis. 1957;16:494-502
21. Benito MJ,Veale DJ,FitzGerald O, et al.Synovial tissue inflammation in early and late osteoarthritis.Ann Rheum Dis. 2005;64:1263-1267
22. Binder NB,Niederreiter B,Hoffmann O, et al.Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.Nat Med. 2009;15:417-424
23. Haseeb A,Haqqi TM.Immunopathogenesis of osteoarthritis.Clin Immunol. 2013;146:185-196
24. Arden NK,Leyland KM.Osteoarthritis year 2013 in review: clinical.Osteoarthr Cartil. 2013;21:1409-1413
25. Klosowska K,Volin MV,Huynh N, et al.Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogen-activated protein kinases and Akt.Clin Exp Immunol. 2009;156:312-319
26. Ajuebor MN,Flower RJ,Hannon R, et al.Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model.J Leukoc Biol. 1998;63:108-116
27. Kurth I,Willimann K,Schaerli P, et al.Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development.J Exp Med. 2001;194:855-861
28. Sturmer T,Brenner H,Koenig W, et al.Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein.Ann Rheum Dis. 2004;63:200-205